The Rheumatologist’s Role in Covid-19

From the Department of Pediatrics, Division of Rheumatology (RQC) and the Department of Medicine, Division of Clinical Immunology and Rheumatology (WWC), University of Alabama at Birmingham. Dr. Cron serves as a consultant to Novartis, Pfizer, and SOBI. Dr. Chatham has served as a consultant to Novartis and SOBI. Drs. Cron and Chatham are co-Principal Investigators on an investigator initiated clinical trial to study interleukin-1 blockade in treating secondary hemophagocytic lymphohistiocytosis in children and adults that is funded by Swedish Orphan Biovitrum, Inc. (SOBI) []. Address correspondence to Randy Q. Cron, MD, PhD, Children’s of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, suite G10, Birmingham, AL 35233-1711. E-mail: rcron@peds.uab.edu.

From the Department of Pediatrics, Division of Rheumatology (RQC) and the Department of Medicine, Division of Clinical Immunology and Rheumatology (WWC), University of Alabama at Birmingham. Dr. Cron serves as a consultant to Novartis, Pfizer, and SOBI. Dr. Chatham has served as a consultant to Novartis and SOBI. Drs. Cron and Chatham are co-Principal Investigators on an investigator initiated clinical trial to study interleukin-1 blockade in treating secondary hemophagocytic lymphohistiocytosis in children and adults that is funded by Swedish Orphan Biovitrum, Inc. (SOBI) []. Address correspondence to Randy Q. Cron, MD, PhD, Children’s of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, suite G10, Birmingham, AL 35233-1711. E-mail: rcron@peds.uab.edu.